v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues:    
Revenues $ 44,747 $ 35,704
Operating expenses:    
Cost of revenues 31,449 23,293
Amortization of capitalized research and development costs 305,413
General and administrative expenses 193,773 112,387
Research and development 47,822
Sales and marketing 180,620 37,302
Professional fees 80,656 571,873
Total Operating Expenses 839,733 744,855
LOSS FROM OPERATIONS (794,986) (709,151)
OTHER INCOME (EXPENSE):    
Financial income (expenses), net 17,838 (13,067)
Total Other Income (Expense) 17,838 (13,067)
Net loss before taxes (777,148) (722,218)
Income tax provision 15,560
Net loss $ (777,148) $ (737,778)
Net loss per share (Class A and Class B common stock), basic $ (0.005) $ (0.005)
Net loss per share (Class A and Class B common stock), diluted $ (0.005) $ (0.005)
Weighted average shares outstanding (Class A and Class B common stock), basic 154,898,024 154,731,170
Weighted average shares outstanding (Class A and Class B common stock), diluted 154,898,024 154,731,170